4//SEC Filing
PYSZCZYMUKA GREG 4
Accession 0000912282-24-000682
CIK 0001385818other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:18 PM ET
Size
7.0 KB
Accession
0000912282-24-000682
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2024-09-30+209→ 23,185 total - Exercise/Conversion
Restricted Stock Units
2024-09-30−209→ 417 total→ Common Shares (209 underlying)
Footnotes (1)
- [F1]Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest quarterly beginning March 31, 2023 and ending March 31, 2025.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001952920
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:18 PM ET
- Size
- 7.0 KB